Medibank stock yields 4.05 percent at 20.40 times earnings

Published on 10/20/2026 at 19:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Its 52-week range is AUD 4.06 to AUD 5.31 and market cap is AUD 13.10 billion. Medibank stock costs EUR 3.00 on October 20, 2026 at Lang & Schwarz.

Yield and valuation figures

Medibank's dividend yield was 4.05 percent and its trailing P/E was 20.40 times on October 17, 2026.
The insurer's 52-week range was AUD 4.06 to AUD 5.31, with market capitalization of AUD 13.10 billion.
Medibank stock was last at EUR 3.00 at Lang & Schwarz on October 20, 2026 at 7:29 p.m. CEST.
The annual meeting is scheduled for November 18, 2026.

Medibank, AU000000MPL3, Illustration mit AI erstellt.

Medibank's dividend yield stood at 4.05 percent and its trailing P/E at 20.40 times in an analysis updated October 17, 2026, according to Simply Wall St. The figures frame Medibank as an income stock with a valuation multiple that remains central to the investment case. Medibank was last at EUR 3.00 at Lang & Schwarz on October 20, 2026 at 7:29 p.m. CEST.

Yield remains central

The 4.05 percent yield was higher than the 3.10 percent industry average cited by Simply Wall St in its October 17, 2026 analysis. That comparison gives the dividend a clear place in the stock story, although the same source said the payout was not covered by free cash flow.

Medibank operates private health insurance in Australia through its insurance business and a health services segment, according to Simply Wall St. The company serves more than 4 million customers, a scale that makes retention and claims management important drivers of future margins.

Price range and valuation

The ASX quote was AUD 4.78 on October 20, 2026 at 4:10 p.m. AEDT, while the 52-week range was AUD 4.06 to AUD 5.31. Market capitalization stood at AUD 13.10 billion and the trailing P/E was 20.78 times in the same market snapshot.

Simply Wall St listed Medibank's primary exchange as the ASX and its ticker as MPL in its October 17, 2026 company analysis. The stock's 4.05 percent yield and 20.40 times trailing P/E therefore provide the main valuation markers alongside the current AUD 13.10 billion market value.

Next date for shareholders

Medibank's annual meeting is scheduled for November 18, 2026, according to Simply Wall St. The date gives investors the next fixed corporate event after the fiscal 2026 reporting cycle.

Medibank's valuation picture combines a 4.05 percent dividend yield with a trailing P/E near 20 times and a 52-week range of AUD 4.06 to AUD 5.31. The balance between income, earnings growth and cash-flow coverage remains the key reading for the stock.

Medibank price in euros

Medibank was last at EUR 3.00 at Lang & Schwarz on October 20, 2026 at 7:29 p.m. CEST. The Australian listing had closed at AUD 4.78 on the ASX at 4:10 p.m. AEDT on the same date. The further course of trading is shown by the continuously updated real-time quote of Medibank stock.